BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9863958)

  • 1. Determination of fluoxetine and norfluoxetine in human plasma by high-pressure liquid chromatography with fluorescence detection.
    Raggi MA; Mandrioli R; Casamenti G; Bugamelli F; Volterra V
    J Pharm Biomed Anal; 1998 Oct; 18(1-2):193-9. PubMed ID: 9863958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid HPLC-DAD method for the analysis of fluoxetine and norfluoxetine in plasma from overdose patients.
    Sabbioni C; Bugamelli F; Varani G; Mercolini L; Musenga A; Saracino MA; Fanali S; Raggi MA
    J Pharm Biomed Anal; 2004 Oct; 36(2):351-6. PubMed ID: 15496328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of fluoxetine, norfluoxetine and their enantiomers in rat plasma and brain samples by liquid chromatography with fluorescence detection.
    Unceta N; Barrondo S; Ruiz de Azúa I; Gómez-Caballero A; Goicolea MA; Sallés J; Barrio RJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):519-28. PubMed ID: 17329174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-phase, liquid-phase microextraction combined with high performance liquid chromatography-fluorescence detection for the simultaneous determination of fluoxetine and norfluoxetine in human plasma.
    de Freitas DF; Porto CE; Vieira EP; de Siqueira ME
    J Pharm Biomed Anal; 2010 Jan; 51(1):170-7. PubMed ID: 19683889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of fluoxetine and norfluoxetine in rat plasma by HPLC with pre-column derivatization and fluorescence detection.
    Guo X; Fukushima T; Li F; Imai K
    Biomed Chromatogr; 2003 Jan; 17(1):1-5. PubMed ID: 12582998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive and selective liquid-chromatographic assay of fluoxetine and norfluoxetine in plasma with fluorescence detection after precolumn derivatization.
    Suckow RF; Zhang MF; Cooper TB
    Clin Chem; 1992 Sep; 38(9):1756-61. PubMed ID: 1526010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of fluoxetine and norfluoxetine enantiomers in human plasma by polypyrrole-coated capillary in-tube solid-phase microextraction coupled with liquid chromatography-fluorescence detection.
    Silva BJ; Lanças FM; Queiroz ME
    J Chromatogr A; 2009 Dec; 1216(49):8590-7. PubMed ID: 19879589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trace analysis of fluoxetine and its metabolite norfluoxetine. Part I: development of a chiral liquid chromatography-tandem mass spectrometry method for wastewater samples.
    Barclay VK; Tyrefors NL; Johansson IM; Pettersson CE
    J Chromatogr A; 2011 Aug; 1218(33):5587-96. PubMed ID: 21752386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive liquid chromatographic-tandem mass spectrometric method for the determination of fluoxetine and its primary active metabolite norfluoxetine in human plasma.
    Sutherland FC; Badenhorst D; de Jager AD; Scanes T; Hundt HK; Swart KJ; Hundt AF
    J Chromatogr A; 2001 Apr; 914(1-2):45-51. PubMed ID: 11358229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-phase microextraction-liquid chromatography (SPME-LC) determination of fluoxetine and norfluoxetine in plasma using a heated liquid flow through interface.
    Fernandes C; Neto AJ; Rodrigues JC; Alves C; Lanças FM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 847(2):217-23. PubMed ID: 17081810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of liquid chromatography with fluorescence detection to liquid chromatography-mass spectrometry for the determination of fluoxetine and norfluoxetine in human plasma.
    Kovacevic I; Pokrajac M; Miljkovic B; Jovanovic D; Prostran M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):372-6. PubMed ID: 16356789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of fluoxetine and its major active metabolite norfluoxetine in human plasma by LC-MS/MS using supported liquid extraction.
    Li Y; Emm T; Yeleswaram S
    Biomed Chromatogr; 2011 Nov; 25(11):1245-51. PubMed ID: 21308704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A validated enantioselective assay for the simultaneous quantitation of (R)-, (S)-fluoxetine and (R)-, (S)-norfluoxetine in ovine plasma using liquid chromatography with tandem mass spectrometry (LC/MS/MS).
    Chow TW; Szeitz A; Rurak DW; Riggs KW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Feb; 879(5-6):349-58. PubMed ID: 21242112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous analysis of olanzapine, fluoxetine, and norfluoxetine in human plasma using liquid chromatography-mass spectrometry and its application to a pharmacokinetic study.
    Ni XJ; Wang ZZ; Shang DW; Lu HY; Zhang M; Wen YG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():506-514. PubMed ID: 30008307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved enantioselective assay for the determination of fluoxetine and norfluoxetine enantiomers in human plasma by liquid chromatography.
    Gatti G; Bonomi I; Marchiselli R; Fattore C; Spina E; Scordo G; Pacifici R; Perucca E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Feb; 784(2):375-83. PubMed ID: 12505785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid analysis of fluoxetine and its metabolite in plasma by LC-MS with column-switching approach.
    Souverain S; Mottaz M; Cherkaoui S; Veuthey JL
    Anal Bioanal Chem; 2003 Nov; 377(5):880-5. PubMed ID: 12955393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid chromatography/tandem mass spectrometry for the determination of fluoxetine and its main active metabolite norfluoxetine in human plasma with deuterated fluoxetine as internal standard.
    Li C; Ji Z; Nan F; Shao Q; Liu P; Dai J; Zhen J; Yuan H; Xu F; Cui J; Huang B; Zhang M; Yu C
    Rapid Commun Mass Spectrom; 2002; 16(19):1844-50. PubMed ID: 12271449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of fluoxetine and norfluoxetine by high-performance liquid chromatography.
    Wong SH; Dellafera SS; Fernandes R; Kranzler H
    J Chromatogr; 1990 Jan; 499():601-8. PubMed ID: 2324217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of fluoxetine and norfluoxetine in human plasma by high-performance liquid chromatography with ultraviolet detection in psychiatric patients.
    LLerena A; Dorado P; Berecz R; González A; Jesús Norberto M; de la Rubia A; Cáceres M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 783(1):25-31. PubMed ID: 12450521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the antidepressant fluoxetine and its metabolite norfluoxetine in serum by reversed-phase HPLC with ultraviolet detection.
    Orsulak PJ; Kenney JT; Debus JR; Crowley G; Wittman PD
    Clin Chem; 1988 Sep; 34(9):1875-8. PubMed ID: 3262022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.